Table 3.
Linear mixed models of physical activity over time comparing the pooled higher doses group (≥1000 IU/d) versus the control group (200 IU/d).
| Model 1 (n=571) | Model 2 (n=566) | Model 3 (n=565) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | B | SE | p value | B | SE | p value | B | SE | p value |
| TAC | |||||||||
| Baseline TAC | 0.859 | 0.019 | <0.001 | 0.839 | 0.021 | <0.001 | 0.826 | 0.021 | <0.001 |
| Timea | −24979 | 15705 | 0.113 | −23612 | 15729 | 0.134 | −23810 | 15727 | 0.131 |
| Dose group | 6476 | 29607 | 0.827 | 5962 | 29695 | 0.841 | 7817 | 29686 | 0.793 |
| Dose group*timea | −10099 | 19750 | 0.610 | −11332 | 19811 | 0.568 | −10886 | 19838 | 0.584 |
| Serum vitamin Db | 7004 | 37293 | 0.851 | −1407 | 37584 | 0.970 | −2507 | 37506 | 0.947 |
| Time*serum vitamin D | −41911 | 21109 | 0.048 | −40534 | 21166 | 0.057 | −40302 | 21179 | 0.058 |
| Dose group*serum vitamin D | 12713 | 48377 | 0.793 | 20458 | 48591 | 0.674 | 21146 | 48433 | 0.663 |
| ASTP (%) | |||||||||
| Baseline ASTP | 0.842 | 0.021 | <0.001 | 0.817 | 0.022 | <0.001 | 0.808 | 0.022 | <0.001 |
| Timea | 0.307 | 0.231 | 0.185 | 0.290 | 0.231 | 0.209 | 0.287 | 0.230 | 0.213 |
| Dose group | 0.093 | 0.378 | 0.807 | 0.063 | 0.379 | 0.869 | 0.037 | 0.381 | 0.922 |
| Dose group*timea | −0.043 | 0.290 | 0.882 | −0.055 | 0.290 | 0.851 | −0.073 | 0.291 | 0.803 |
| Serum vitamin D | −0.023 | 0.477 | 0.962 | 0.057 | 0.480 | 0.905 | 0.066 | 0.481 | 0.892 |
| Time*serum vitamin D | 0.607 | 0.310 | 0.051 | 0.627 | 0.310 | 0.045 | 0.636 | 0.310 | 0.042 |
| Dose group*serum vitamin D | −0.486 | 0.624 | 0.437 | −0.567 | 0.624 | 0.364 | −0.573 | 0.624 | 0.360 |
| Active time (min/day) | |||||||||
| Baseline active time | 0.844 | 0.021 | <0.001 | 0.828 | 0.022 | <0.001 | 0.820 | 0.022 | <0.001 |
| Timea | −4.93 | 3.44 | 0.153 | −4.66 | 3.45 | 0.177 | −4.76 | 3.44 | 0.168 |
| Dose group | −0.643 | 6.15 | 0.917 | −0.525 | 6.19 | 0.933 | 0.021 | 6.19 | 0.997 |
| Dose group*timea | 1.42 | 4.33 | 0.742 | 1.21 | 4.34 | 0.782 | 1.08 | 4.34 | 0.805 |
| Serum vitamin D | 0.443 | 7.71 | 0.954 | −0.636 | 7.80 | 0.935 | −0.940 | 7.79 | 0.904 |
| Time*serum vitamin D | −11.80 | 4.63 | 0.011 | −11.57 | 4.64 | 0.013 | −11.41 | 4.64 | 0.015 |
| Dose group*serum vitamin D | 7.83 | 9.85 | 0.428 | 8.63 | 9.93 | 0.386 | 8.75 | 9.92 | 0.379 |
Note. N=571. TAC = total activity counts, ASTP = Activity fragmentation defined by the active-to-sedentary transition probability
Time=0 at baseline, 0.25 at 3 months follow-up visit, 1 at 12 months follow-up visit, and 2 at 24 months follow-up visit.
Linear mixed effects model with random intercept and slope, using unstructured correlation structure. Model 1 was the unadjusted model; Model 2 was adjusted for age, sex, and race (non-white vs. white); Model 3 was additionally adjusted for BMI, number of comorbidities, and history of falls (fell vs. did not fall).
Baseline serum vitamin D at 10–19 ng/mL (deficient) vs. 20–29 ng/mL (low).